Is Stanrose Mafat. overvalued or undervalued?

As of 19 September 2025, the valuation grade for Stanrose Mafat. has moved from very expensive to risky, indicating a significant shift in its perceived value. The company is currently assessed as undervalued, primarily due to its low Price to Book Value of 0.67 and negative PE Ratio of -14.04, which suggests that the market may not be fully recognizing its potential. Additionally, the EV to EBITDA stands at -0.85, further highlighting the challenges it faces in generating positive earnings relative to its enterprise value.
In comparison to its peers, Stanrose Mafat. appears to be undervalued when contrasted with Bajaj Finance, which has a PE Ratio of 35.51, and Life Insurance, which boasts a PE Ratio of 11.64. This disparity underscores the potential for upside in Stanrose Mafat.'s valuation. Notably, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -12.94% compared to the Sensex's 5.74%, reinforcing the notion that the stock may be undervalued relative to its market peers.